Bicnu Related Clinical Trials
The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme [Active, not recruiting]
Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme [Recruiting]
Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme. [Recruiting]
Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma [Active, not recruiting]
A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM) [Not yet recruiting]
Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas [Completed]
Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma [Completed]
Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer [Recruiting]
Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma [Completed]
Radiation With Concomitant and Then Sequential Temozolomide in Malignant Glioma [Recruiting]
Carmustine in Treating Patients With Recurrent Malignant Glioma [Completed]
O6-Benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma [Completed]
O6-Benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma [Active, not recruiting]
Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM [Recruiting]
O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma [Completed]
Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme [Recruiting]
Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients [Recruiting]
Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme [Active, not recruiting]
Radiation Therapy and Carmustine With or Without O6-Benzylguanine in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma [Active, not recruiting]
Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme [Active, not recruiting]
Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme [Completed]
Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma [Recruiting]
Carmustine Plus O6-Benzylguanine in Treating Patients With Recurrent or Progressive Glioma [Completed]
Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms [Active, not recruiting]
Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma [Active, not recruiting]
Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain [Active, not recruiting]
Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma [Active, not recruiting]
O6-Benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors [Active, not recruiting]
O6-Benzylguanine And Carmustine in Treating Patients With Multiple Myeloma [Completed]
O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors [Completed]
Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma [Completed]
Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Suspended]
Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma [Not yet recruiting]
Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm [Active, not recruiting]
O(6)-Benzylguanine and Carmustine in Treating Patients With Stage I or Stage II Cutaneous T-Cell Lymphoma [Active, not recruiting]
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma [Active, not recruiting]
Carmustine Implants in Treating Patients With Brain Metastases [Completed]
Rituximab and Carmustine, Cytarabine, Etoposide, and Melphalan Followed By Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With B-Cell Non-Hodgkin's Lymphoma [Completed]
Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme [Recruiting]
Temozolomide, Carmustine, O6-Benzylguanine, Radiation Therapy, and an Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma [Not yet recruiting]
Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation [Recruiting]
Bortezomib and Reduced Intensity Allogenic Stem Cell Transplantation for Lymphoid Malignancies [Recruiting]
Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation [Recruiting]
Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas [Active, not recruiting]
Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer [Active, not recruiting]
Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Completed]
Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma [Active, not recruiting]
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [Active, not recruiting]
A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade Glioma [Recruiting]
A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma [Recruiting]
Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease [Recruiting]
Combination Chemotherapy and Antithymocyte Globulin Followed By Stem Cell Transplant in Treating Patients With Severe Autoimmune Neurologic Diseases That Did Not Respond to Previous Therapy [Recruiting]
Chemotherapy in Treating Patients With Recurrent Malignant Glioma [Active, not recruiting]
High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study [Recruiting]
Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme [Active, not recruiting]
Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma [Active, not recruiting]
Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia [Active, not recruiting]
Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies [Recruiting]
Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma [Recruiting]
Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies [Recruiting]
Freiburg ZNS-NHL Study [Recruiting]
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors [Recruiting]
Peripheral Stem Transplantation in Treating Patients With Refractory or Relapsed Lymphoma [Recruiting]
Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma [Recruiting]
Yttrium Y 90 Ibritumomab Tiuxetan With or Without Rituximab, Combination Chemotherapy, and an Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma [Recruiting]
High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma [Recruiting]
GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma [Recruiting]
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant [Not yet recruiting]
Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer [Recruiting]
Palonosetron, Aprepitant, and Low-Dose Dexamethasone in Preventing Nausea and Vomiting in Patients Undergoing High-Dose Chemotherapy and Stem Cell Transplant for Multiple Myeloma or Lymphoma [Recruiting]
Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia [Recruiting]
Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma [Not yet recruiting]
Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma [Recruiting]
Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia [Not yet recruiting]
Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma [Recruiting]
Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer [Recruiting]
Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma [Recruiting]
Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma [Recruiting]
Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma [Recruiting]
Comparison of Rituxan Versus Bexxar When Combined With Carmustine, Etoposide, Cytarabine and Melphalan (BEAM) With Autologous Hematopoietic Stem Cell Transplantation (ASCT) [Recruiting]
Efficacy of Rituximab - Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) Versus R-CHOP/R-DHAP in Patients With Untreated Mantle Cell Lymphoma [Recruiting]
Docetaxel and Vinorelbine Plus Sargramostim in Malignant Melanoma [Recruiting]
VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma [Recruiting]
Reduced Intensity Conditioning Transplantation vs Standard of Care in Acute Myeloid Leukemia [Recruiting]
|
